Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults.

Rajaraman P, Schwartz BS, Rothman N, Yeager M, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Environ Health Perspect. 2005 Sep;113(9):1209-11.

2.

Lead, genetic susceptibility, and risk of adult brain tumors.

Rajaraman P, Stewart PA, Samet JM, Schwartz BS, Linet MS, Zahm SH, Rothman N, Yeager M, Fine HA, Black PM, Loeffler J, Shapiro WR, Selker RG, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2514-20.

3.

Ethnicity affects the distribution of delta-aminolevulinic acid dehydratase (ALAD) genetic variants.

Montenegro MF, Barbosa F Jr, Sandrim VC, Gerlach RF, Tanus-Santos JE.

Clin Chim Acta. 2006 May;367(1-2):192-5. Epub 2006 Jan 30.

PMID:
16445899
4.
5.

Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review.

Kelada SN, Shelton E, Kaufmann RB, Khoury MJ.

Am J Epidemiol. 2001 Jul 1;154(1):1-13. Review.

PMID:
11427399
6.

A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio.

Montenegro MF, Barbosa F Jr, Sandrim VC, Gerlach RF, Tanus-Santos JE.

Arch Toxicol. 2006 Jul;80(7):394-8. Epub 2005 Dec 9.

PMID:
16341691
7.

XRCC1 and XRCC3 variants and risk of glioma and meningioma.

Kiuru A, Lindholm C, Heinävaara S, Ilus T, Jokinen P, Haapasalo H, Salminen T, Christensen HC, Feychting M, Johansen C, Lönn S, Malmer B, Schoemaker MJ, Swerdlow AJ, Auvinen A.

J Neurooncol. 2008 Jun;88(2):135-42. doi: 10.1007/s11060-008-9556-y.

PMID:
18330515
8.

Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors.

De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS, Bell DA.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):14-22.

9.

Ethnic variation in genotype frequencies of delta-aminolevulinic acid dehydratase (ALAD).

Fujihara J, Agusa T, Yasuda T, Soejima M, Kato H, Panduro A, Koda Y, Kimura-Kataoka K, Takeshita H.

Toxicol Lett. 2009 Dec 15;191(2-3):236-9. doi: 10.1016/j.toxlet.2009.09.005. Epub 2009 Sep 17.

PMID:
19766174
10.

δ-Aminolevulinic acid dehydratase genotype predicts toxic effects of lead on workers' peripheral nervous system.

Zheng G, Tian L, Liang Y, Broberg K, Lei L, Guo W, Nilsson J, Bergdahl IA, Skerfving S, Jin T.

Neurotoxicology. 2011 Aug;32(4):374-82. doi: 10.1016/j.neuro.2011.03.006. Epub 2011 Mar 23.

PMID:
21439310
11.

Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients.

Taha MM, Gaber OA, Sabbah NA, Abd Elazem AA.

Mol Clin Oncol. 2015 Sep;3(5):995-1000. Epub 2015 Jun 25.

12.

[Lack of association between alcoholism and alleles in the delta-aminolevulinic acid dehydratase (ALAD) gene].

Muramatsu T, Harada S, Higuchi S, Murayama M, Matsushita S, Hayashida M.

Arukoru Kenkyuto Yakubutsu Ison. 1994 Jun;29(3):179-84. Japanese.

PMID:
8080400
13.
14.
15.

Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes.

Kamel F, Umbach DM, Lehman TA, Park LP, Munsat TL, Shefner JM, Sandler DP, Hu H, Taylor JA.

Environ Health Perspect. 2003 Aug;111(10):1335-9.

16.

Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes.

Lee BK, Lee GS, Stewart WF, Ahn KD, Simon D, Kelsey KT, Todd AC, Schwartz BS.

Environ Health Perspect. 2001 Apr;109(4):383-9.

17.

Meningioma and schwannoma risk in adults in relation to family history of cancer.

Hill DA, Linet MS, Black PM, Fine HA, Selker RG, Shapiro WR, Inskip PD.

Neuro Oncol. 2004 Oct;6(4):274-80.

18.
19.

Season of birth and risk of brain tumors in adults.

Brenner AV, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.

Neurology. 2004 Jul 27;63(2):276-81.

PMID:
15277620
20.

Association between delta-aminolevulinic acid dehydratase polymorphism and placental lead levels.

Kayaaltı Z, Sert S, Kaya-Akyüzlü D, Söylemez E, Söylemezoğlu T.

Environ Toxicol Pharmacol. 2016 Jan;41:147-51. doi: 10.1016/j.etap.2015.11.017. Epub 2015 Dec 3.

PMID:
26701682

Supplemental Content

Support Center